Health Trials

Hepatic Impairment and Healthy Female

2

Review clinical trials related to Hepatic Impairment and Healthy Female. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function

This study is a Phase I, single-dose, open-label trial designed to evaluate the pharmacokinetics and safety of a single oral dose of 25 mg VC005 tablets in participants with mild and moderate hepatic impairment compared to participants with normal hepatic function.

Participants needed: 24
Trial details
Phase: Phase 1Age: 18-79Biological sex: AllType: InterventionalSponsor: Jiangsu vcare pharmaceutical technology co., LTDUpdated: Apr 27, 2026Locations: 1
Eligibility criteria

Voluntarily sign the informed consent form prior to the trial, fully understand... [+3]

History of allergies, including to drugs, food, dust mites, etc., known allergy... [+6]

Read more
Status: Not yet recruiting

GS1-144 in Participants With Hepatic Impairment and Healthy Female

GS1-144 in Participants with Hepatic Impairment and Healthy Female

Participants needed: 24
Trial details
Phase: Phase 1Age: 18-70Biological sex: FemaleType: InterventionalSponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Updated: Mar 24, 2026Locations: 1
Eligibility criteria

Participants who sign the ICF prior to the trial, have a full understanding of t... [+8]

Allergic constitution (e.g., allergy to more than two drugs or foods), or a hist... [+18]

Read more